Telomir Pharmaceuticals, Inc. (TELO): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Telomir Pharmaceuticals, Inc. (TELO) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 Consulting Agreement This Consulting Agreement (this “Agreement”) is entered into as of June 6, 2026 (“Effective Date”) by and between Telomir Pharmaceuticals, Inc. (“Company”) and Andriy Mushak (“Consultant”). Company and Consultant may
How this was made
The 30-second read
Why it matters
This may reduce execution risk around reporting and audit processes, but it does not provide new operational milestones, trial results, or funding terms.
Market read
A governance/finance-operations update with limited direct trading implications unless it precedes a financing or major corporate action.
What to watch
Traders may watch for follow-on 8-Ks/financing announcements; this document alone is not a catalyst.
Background
The 8-K Item 5.02 attaches a consulting agreement for a fractional CFO role focused on SEC compliance, audit readiness, internal controls, and capital-markets support.
Ticker impact
Telomir Pharmaceuticals disclosed an 8-K Item 5.02 appointing a fractional CFO consultant under a new consulting agreement.
Likely limited near-term impact; any effect would be indirect via improved SEC/audit readiness and capital-markets support.
The agreement details scope and $6,000/month compensation but does not disclose new clinical, regulatory, financing, or commercial outcomes.
Market effects
Minimal; fractional CFO/SEC readiness arrangements are not a sector-wide signal.
None indicated.
None indicated.
Counterpoint
The appointment could signal internal capacity constraints or upcoming financing/transaction work, but the filing itself does not confirm that.
Key entities
- issuerTelomir Pharmaceuticals, Inc.
Company filing the 8-K and entering the fractional CFO consulting agreement.
- consultantAndriy Mushak
Fractional CFO consultant engaged for SEC reporting oversight and related finance services.